IperionX Limited (IPX)

Verve Therapeutics Statistics

Total Valuation

IperionX has a market cap or net worth of $1.30 billion. The enterprise value is $1.22 billion.

Market Cap	1.30B
Enterprise Value	1.22B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

IperionX has 315.85 million shares outstanding. The number of shares has increased by 24.08% in one year.

Current Share Class	n/a
Shares Outstanding	315.85M
Shares Change (YoY)	+24.08%
Shares Change (QoQ)	+19.85%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	245.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	12.32
P/TBV Ratio	14.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.80, with a Debt / Equity ratio of 0.04.

Current Ratio	11.80
Quick Ratio	11.70
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-154.47

Financial Efficiency

Return on equity (ROE) is -40.65% and return on invested capital (ROIC) is -29.17%.

Return on Equity (ROE)	-40.65%
Return on Assets (ROA)	-27.56%
Return on Invested Capital (ROIC)	-29.17%
Return on Capital Employed (ROCE)	-30.27%
Revenue Per Employee	n/a
Profits Per Employee	-$919,517
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +192.20% in the last 52 weeks. The beta is 0.39, so IperionX's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	+192.20%
50-Day Moving Average	31.21
200-Day Moving Average	25.92
Relative Strength Index (RSI)	64.28
Average Volume (20 Days)	75,541

Short Selling Information

Short Interest	182,705
Short Previous Month	158,967
Short % of Shares Out	0.65%
Short % of Float	n/a
Short Ratio (days to cover)	2.55

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-33.04M
Pretax Income	-19.19M
Net Income	-27.59M
EBITDA	-32.62M
EBIT	-33.04M
Earnings Per Share (EPS)	-$0.11

Balance Sheet

The company has $77.13 million in cash and $4.19 million in debt, giving a net cash position of $72.93 million or $0.23 per share.

Cash & Cash Equivalents	77.13M
Total Debt	4.19M
Net Cash	72.93M
Net Cash Per Share	$0.23
Equity (Book Value)	105.54M
Book Value Per Share	0.33
Working Capital	72.10M

Cash Flow

In the last 12 months, operating cash flow was -$22.38 million and capital expenditures -$7.71 million, giving a free cash flow of -$30.09 million.

Operating Cash Flow	-22.38M
Capital Expenditures	-7.71M
Free Cash Flow	-30.09M
FCF Per Share	-$0.10

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IperionX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.08%
Shareholder Yield	-24.08%
Earnings Yield	-2.12%
FCF Yield	-2.31%

Analyst Forecast

The average price target for IperionX is $28.00, which is -29.82% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$28.00
Price Target Difference	-29.82%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3